BeOne Medicines
ONC
#739
Rank
A$45.15 B
Marketcap
A$393.16
Share price
-2.63%
Change (1 day)
-1.88%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): A$0.85

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$0.93. In 2024 the company made an earnings per share (EPS) of A-$8.91.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.85-109.58%
2024A-$8.91
2022A-$27.8528.21%
2021A-$21.72-19.96%
2020A-$27.1420.81%
2019A-$22.4731.52%
2018A-$17.08417.57%
2017A-$3.30-37.16%
2016A-$5.25158.95%
2015A-$2.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.34-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.36-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA